Related Experiment Video
Updated: May 20, 2025

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
Managing discordance between HbA1c and glucose management indicator
Erna Lenters-Westra1,2, Marion Fokkert1, Eric S Kilpatrick3
1Department of Clinical Chemistry, Isala, Zwolle, the Netherlands.
Insights
Discrepancies between HbA1c and Glucose Management Indicator (GMI) can impact diabetes care. This checklist helps identify and mitigate errors from Continuous Glucose Monitoring (CGM) and HbA1c measurements for improved patient outcomes.
Area of Science:
- Endocrinology and Metabolism
- Clinical Diagnostics
- Biomedical Engineering
Background:
- Hemoglobin A1c (HbA1c) is crucial for diabetes management.
- Continuous Glucose Monitoring (CGM) offers real-time glucose data.
- Discordance between HbA1c and Glucose Management Indicator (GMI) presents clinical challenges.
Purpose of the Study:
- To present a checklist of potential error sources for GMI and HbA1c values.
- To provide mitigation strategies for identified discrepancies.
- To enhance the accuracy of glycaemic control assessment in diabetes care.
Main Methods:
- Literature review on GMI and HbA1c measurement techniques.
- Identification of factors contributing to discordance between GMI and HbA1c.
- Development of a reference checklist for error mitigation.
Main Results:
- A checklist detailing common sources of discordance between HbA1c and GMI has been developed.
- Factors include Continuous Glucose Monitoring (CGM) accuracy and sensor calibration.
- Physiological conditions and red blood cell turnover also contribute to discrepancies.
Conclusions:
- Glucose Management Indicator (GMI) is increasingly utilized in diabetes care.
- Understanding potential causes of GMI and HbA1c discordance is essential for CGM users.
- Equipping patients and providers with knowledge improves diabetes management.
Aims:
The assessment of haemoglobin A1c (HbA1c) continues to play an essential role in diabetes care; however, major advances in new technologies widen the armament available to clinicians to further refine treatment for their patients. Whilst HbA1c remains a critical glycaemic marker, advances in technologies such as Continuous Glucose Monitoring (CGM) now offer real-time glucose monitoring, allowing a more instant assessment of glycaemic control. Discrepancies between laboratory-measured HbA1c and Glucose Management Indicator (GMI) values are a significant clinical issue. In this article, we present a checklist of potential sources of error for both GMI and HbA1c values and provide suggestions to mitigate these sources in order to continue to improve diabetes care.
Methods:
We identified key literature pertaining to GMI measurement, HbA1c measurement, and potential factors of discordance between the two. Using these sources, we explore the potential factors leading to discordance and how to mitigate these when found.
Results:
We have constructed a quick reference checklist covering the main sources of discordance between HbA1c and GMI, with accompanying narrative text for more detailed discussion. Discordance can arise due to various factors, including CGM accuracy, sensor calibration, red blood cell turnover and other physiological conditions.
Conclusions:
GMI will likely continue to be used in the upcoming years by both persons with diabetes and their health care providers, and so it is important for users of CGM devices to be equipped with the knowledge to understand the potential causes of discordance between GMI and HbA1c values.
More Related Videos
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Hypoglycemia and Glucagon
Homeostatic Imbalance
However, sometimes these feedback loops fail,...